Kristin C Jensen

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint Characterization of a novel anti-fatty acid synthase (FASN) antiserum in breast tissue
    Kristin C Jensen
    Department of Pathology, Stanford University Medical Center, Stanford, CA 94305, USA
    Mod Pathol 21:1413-20. 2008
  2. doi request reprint New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up
    K C Jensen
    Stanford University, Stanford, CA 94305, USA
    Breast Cancer Res Treat 112:453-9. 2008
  3. doi request reprint Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger
    Kristin C Jensen
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Am J Surg Pathol 32:1029-37. 2008
  4. pmc Variations in stromal signatures in breast and colorectal cancer metastases
    Jonathan A Webster
    Department of Pathology, Stanford University Medical Center, Stanford, CA, USA
    J Pathol 222:158-65. 2010
  5. doi request reprint Clinicopathologic characteristics of HER2 FISH-ambiguous breast cancer at a single institution
    Michael R Clay
    Department of Pathology, Stanford Hospital and Clinics, Stanford, CA 94305, USA
    Am J Surg Pathol 37:120-7. 2013
  6. ncbi request reprint Chest wall leiomyosarcoma after breast-conservative therapy for early-stage breast cancer in a young woman with Li-Fraumeni syndrome
    Eve Henry
    Department of Medicine, Stanford University, Stanford, California, USA
    J Natl Compr Canc Netw 10:939-42. 2012
  7. ncbi request reprint The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms
    Kristin C Jensen
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Mod Pathol 20:871-7. 2007
  8. doi request reprint Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone
    Cheng Han Lee
    Department of Pathology, Stanford University, Stanford, CA, USA
    Mod Pathol 21:531-9. 2008
  9. pmc Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model
    Sunitha V Bachawal
    Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford University, Stanford, California 94305, USA
    Cancer Res 73:1689-98. 2013
  10. doi request reprint Epidermal growth factor receptor variant III contributes to cancer stem cell phenotypes in invasive breast carcinoma
    Catherine A Del Vecchio
    Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA
    Cancer Res 72:2657-71. 2012

Collaborators

Detail Information

Publications13

  1. doi request reprint Characterization of a novel anti-fatty acid synthase (FASN) antiserum in breast tissue
    Kristin C Jensen
    Department of Pathology, Stanford University Medical Center, Stanford, CA 94305, USA
    Mod Pathol 21:1413-20. 2008
    ..In addition, FASN expression is described in apocrine metaplasia, columnar cell lesions, and flat epithelial atypia...
  2. doi request reprint New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up
    K C Jensen
    Stanford University, Stanford, CA 94305, USA
    Breast Cancer Res Treat 112:453-9. 2008
    ..We examine the natural history of breast cancers in relationship to increased HER2 copy numbers in a large population-based study...
  3. doi request reprint Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger
    Kristin C Jensen
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Am J Surg Pathol 32:1029-37. 2008
    ..The occurrence of MMR inactivation in a significant proportion of ovarian clear cell carcinomas (17% in this study) suggests that this tumor may warrant targeted testing in women <or=50 years of age...
  4. pmc Variations in stromal signatures in breast and colorectal cancer metastases
    Jonathan A Webster
    Department of Pathology, Stanford University Medical Center, Stanford, CA, USA
    J Pathol 222:158-65. 2010
    ..The preservation of the CSF1 macrophage response pattern in metastases lends support to targeting the CSF1 pathway in cancer...
  5. doi request reprint Clinicopathologic characteristics of HER2 FISH-ambiguous breast cancer at a single institution
    Michael R Clay
    Department of Pathology, Stanford Hospital and Clinics, Stanford, CA 94305, USA
    Am J Surg Pathol 37:120-7. 2013
    ..8 to 2.2) cases reflexed to HER2 IHC. This provides a unique dataset for lesions that may not routinely undergo FISH testing. The clinicopathologic characteristics of HER2 FISH-ambiguous cases are described...
  6. ncbi request reprint Chest wall leiomyosarcoma after breast-conservative therapy for early-stage breast cancer in a young woman with Li-Fraumeni syndrome
    Eve Henry
    Department of Medicine, Stanford University, Stanford, California, USA
    J Natl Compr Canc Netw 10:939-42. 2012
    ....
  7. ncbi request reprint The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms
    Kristin C Jensen
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Mod Pathol 20:871-7. 2007
    ..Lastly, we have shown that the lack of its expression at the protein level in many epithelial and mesenchymal neoplasms renders PAX5 expression an extremely specific marker of the B lineage...
  8. doi request reprint Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone
    Cheng Han Lee
    Department of Pathology, Stanford University, Stanford, CA, USA
    Mod Pathol 21:531-9. 2008
    ..These findings altogether show that p63 can be used as a diagnostic marker to aid the clinical diagnosis of GCTOB...
  9. pmc Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model
    Sunitha V Bachawal
    Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford University, Stanford, California 94305, USA
    Cancer Res 73:1689-98. 2013
    ..These results suggest that VEGFR2-targeted ultrasound molecular imaging allows highly accurate detection of DCIS and breast cancer in transgenic mice and may be a promising approach for early breast cancer detection in women...
  10. doi request reprint Epidermal growth factor receptor variant III contributes to cancer stem cell phenotypes in invasive breast carcinoma
    Catherine A Del Vecchio
    Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA
    Cancer Res 72:2657-71. 2012
    ..These data suggest a novel function for EGFRvIII in breast tumorigenesis...
  11. doi request reprint Dynamic real-time microscopy of the urinary tract using confocal laser endomicroscopy
    Katherine Wu
    Department of Urology, Stanford Cancer Center, Stanford University School of Medicine, Stanford, California 94305 5118, USA
    Urology 78:225-31. 2011
    ..The suggested diagnostic criteria will formulate a guide for pCLE image interpretation in urology...
  12. ncbi request reprint Cytologic diagnosis of columnar-cell lesions of the breast
    Kristin C Jensen
    Department of Pathology, Stanford University School of Medicine, Stanford, California 94305 5324, USA
    Diagn Cytopathol 35:73-9. 2007
    ..The prospective diagnosis of CCL cannot reliably be made by fine-needle aspiration. However, it is important to recognize the range of cytologic atypia that can be seen with CCL to avoid an overdiagnosis of malignancy...
  13. ncbi request reprint Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis
    Margrit M Juretzka
    Division of Gynecologic Oncology, Stanford University School of Medicine, Stanford, CA 94305 5317, USA
    Gynecol Oncol 93:107-11. 2004
    ....